Market Research Logo

Asia-pacific Cancer Biomarker Market 2017-2025

Asia-pacific Cancer Biomarker Market 2017-2025KEY FINDINGS

The Asia-Pacific cancer biomarkers market is expected to speed up its growth with a CAGR of 15.73% for the years 2017-2025, generating a net worth of $8831 million. India is the fastest growing market in the Asia-Pacific region.

MARKET INSIGHTS

The market is mainly categorized into diseases and discovery & diagnostics, and further into their sub-segments. The adoption of western lifestyles in developing Asia Pacific regions, prevailing high population, and the growing cancer research in the Asian countries are majorly responsible for accelerating the market growth. However, the low estimated rate for successful clinical trials and the various technical issues related to cancer biomarkers are expected to prove challenging for the market growth.

COMPETITIVE INSIGHTS

Some of the established companies in this market are Qiagen N.V, Agilent Technologies, Ambrilia Biopharma Inc, Agendia N. Roche Diagnostics Ltd, Astellas Pharma Inc, Abbott Laboratories, Biomoda Inc, and Illumina, Inc, V.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Key Findings
4. Market Determinants
4.1. Market Drivers
4.1.1. Adoption Of Western Lifestyles In Developing Regions
4.1.2. Growing Prevalence On Research Of Cancer Biomarkers
4.1.3. Encouragement For Biomarker Development By Fda
4.1.4. Improved Precision And Speed Of Diagnosis
4.1.5. High Investment Through Government And Private Funds In Cancer Related Research
4.1.6. Development Of Highly Specific Drugs
4.2. Restraints
4.2.1. Poor Compensation Structures
4.2.2. Low Estimated Rate Of Successful Clinical Trials Of Biomarkers
4.2.3. Technical Issues Related To Cancer Biomarkers
4.3. Market Opportunities
4.3.1. Wide Opportunity To Grow In Personalized Medication
4.3.2. Supports On Biomarkers Test
4.3.3. Growing Number Of Cancer Patients And Growing Medical Tourism In Emerging Economies
4.4. Market Challenges
4.4.1. Lacking Acceptance Of The Cancer Biomarker
4.4.2. Unfavorable Compensation Situation
4.4.3. High Cost Of Developing Companion Diagnostics
4.4.4. Rigorous Regulatory Agenda
4.4.5. Dearth Of Skilful Workers
5. Market Segmentation
5.1. Market By Discovery And Diagnostics 2017-2025
5.1.1. Biomarker Discovery
5.1.1.1. Genetic Methods
5.1.1.1.1. Dna Arrays
5.1.1.1.2. Polymerase Chain Reaction (Pcr)
5.1.1.1.3. Reverse Transcriptase Polymerase Chain Reaction (Rt-pcr)
5.1.1.1.4. Fluorescent In Situ Hybridization (Fish)
5.1.1.1.5. Southern Blot
5.1.1.2. Imaging
5.1.1.2.1. Magnetic Resonance Imaging (Mri)
5.1.1.2.2. Computed Tomography (Ct)
5.1.1.2.3. Positron Emission Tomography (Pet)
5.1.1.2.4. Ultrasound
5.1.1.2.5. Single-photon Emission Computed Tomography (Spect)
5.1.1.2.6. X-ray
5.1.1.2.7. Magnetic Resonance Spectroscopy (Mrs)
5.1.1.2.8. Biophotonics
5.1.1.3. Protein Methods
5.1.1.3.1. Mass Spectrometry (Ms)
5.1.1.3.2. Immunohistochemistry (Ihc)
5.1.1.4. Metabolomics
5.1.2. Biomarker Diagnostic
5.1.2.1. Genetic And Genomic Markers
5.1.2.2. Proteomics
5.1.2.3. Dna Microarrays
5.1.2.4. Immunoassays
5.1.2.5. Immunohistochemical Tests
5.1.2.6. Pharmacogenomics
5.1.2.7. Molecular (Dna And Genomic) Diagnostic Assays
5.1.2.8. Flow Cytometry
5.1.2.9. Monoclonal Antibodies
5.1.2.10. Stem Cell Markers
5.1.2.11. Invitro Diagnostic Multivariate Index
5.2. Market By Disease 2017-2025
5.2.1. Lung Cancer
5.2.2. Breast Cancer
5.2.3. Colorectal Cancer
5.2.4. Prostate Cancer
5.2.5. Cervical Cancer
5.2.6. Other Cancer
6. Key Analytics
6.1. Porters Five Force Model
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute Product
6.1.3. Bargaining Power Of Buyer
6.1.4. Bargaining Power Of Suppliers
6.1.5. Intensity Of Competitive Rivalry
6.2. Opportunity Matrix
6.3. Key Buying Criteria
6.3.1. Pricing
6.3.2. Efficacy
6.3.3. Application And Effectiveness
6.4. Vendor Landscape
7. Geographic Analysis
7.1. Asia-pacific
7.1.1. China
7.1.2. India
7.1.3. Japan
7.1.4. South Korea
7.1.5. Australia
7.1.6. Rest Of Asia-pacific
8. Company Profiling
8.1. Competitive Landscape
8.1.1. Market Share Analysis
8.1.2. Top Winning Strategies
8.2. Abbott Laboratories
8.2.1. Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Affymetrix, Inc.(Acquired By Thermofisher)
8.3.1. Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Agendia N.V.
8.4.1. Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.4.4. Strategic Initiatives
8.5. Agilent Technologies, Inc.
8.5.1. Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Astellas Pharma Inc.
8.6.1. Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.6.4. Strategic Initiatives
8.7. Becton Dickinson And Company
8.7.1. Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Clarient, Inc. (Acquired By Neogenomics Laboratories)
8.8.1. Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. Diadexus Inc. (Acquired By Diazyme Laboratories)
8.9.1. Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Illumina, Inc
8.10.1. Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Qiagen N.V. Overview
8.11.1. Product Portfolio
8.11.2. Scot Analysis
8.11.3. Strategic Initiatives
8.12. Roche Diagnostics Ltd
8.12.1. Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Ambrilia Biopharma Inc.
8.13.1. Overview
8.13.2. Product Portfolio
8.13.3. Scot Analysis
8.13.4. Strategic Initiatives
8.14. Aureon Biosciences, Inc
8.14.1. Beckman Coulter Overview
8.14.2. Product Portfolio
8.14.3. Scot Analysis
8.14.4. Strategic Initiatives
8.15. Biomoda Inc.
8.15.1. Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives
Table List
Table # 1 Recent Research On Biomarkers
Table # 2 List Of Fda Approved Protein Cancer Biomarkers (2015)
Table # 3 Potential Clinical Uses Of Cancer Biomarkers
Table # 4 Medical Tourism Prices In Us Dollar
Table # 5 Asia-pacific Cancer Biomarker Market, By Discovery And Diagnostics 2017-2025 ($million)
Table # 6 Asia-pacific Genetic Methods Market 2017-2025 ($million)
Table # 7 Asia-pacific Genetic Methods Market,2017-2025 ($million)
Table # 8 Asia-pacific Dna Arrays Market, 2017-2025 ($million)
Table # 9 Asia-pacific Polymerase Chain Reaction Market, 2017-2025 ($million)
Table # 10 Asia-pacific Reverse Transcriptase Polymerase Chain Reaction Market, 2017-2025 ($million)
Table # 11 Asia-pacific Fluorescent In Situ Hybridization Market, 2017-2025 ($million)
Table # 12 Asia-pacific Southern Blot Market, 2017-2025 ($million)
Table # 13 Asia-pacific Imaging Market 2017-2025 ($million)
Table # 14 Asia-pacific Imaging Market, 2017-2025 ($million)
Table # 15 Asia-pacific Magnetic Resonance Imaging Market, 2017-2025 ($million)
Table # 16 Asia-pacific Computed Tomography Market, 2017-2025 ($million)
Table # 17 Asia-pacific Positron Emission Tomography Market, 2017-2025 ($million)
Table # 18 Asia-pacific Ultrasound Market, 2017-2025 ($million)
Table # 19 Asia-pacific Single Photon Emission Computed Tomography Market, 2017-2025 ($million)
Table # 20 Asia-pacific X-ray Market, 2017-2025 ($million)
Table # 21 Asia-pacific Magnetic Resonance Spectroscopy Market, 2017-2025 ($million)
Table # 22 Asia-pacific Biophotonics Market, 2017-2025 ($million)
Table # 23 Asia-pacific Protein Methods Market 2017-2025 ($million)
Table # 24 Asia-pacific Protein Methods Market, 2017-2025 ($million)
Table # 25 Asia-pacific Mass Spectrometry Market, 2017-2025 ($million)
Table # 26 Asia-pacific Immunohistochemistry Market, 2017-2025 ($million)
Table # 27 Asia-pacific Metabolomics Market, 2017-2025 ($million)
Table # 28 Asia-pacific Biomarker Diagnostic Market, 2017-2025 ($million)
Table # 29 Asia-pacific Genomics And Genetic Markers Market, 2017-2025 ($million)
Table # 30 Asia-pacific Proteomics Market, 2017-2025 ($million)
Table # 31 Asia-pacific Dna Microarrays Market, 2017-2025 ($million)
Table # 32 Asia-pacific Immunoassays Market, 2017-2025 ($million)
Table # 33 Asia-pacific Immunohistochemical Tests Market, 2017-2025 ($million)
Table # 34 Asia-pacific Pharmacogenomics Market, 2017-2025 ($million)
Table # 35 Asia-pacific Molecular (Dna And Genomic) Diagnostic Assays Market, 2017-2025 ($million)
Table # 36 Asia-pacific Flow Cytometry Market, 2017-2025 ($million)
Table # 37 Asia-pacific Monoclonal Antibodies Market, 2017-2025 ($million)
Table # 38 Asia-pacific Stem Cell Markers Market, 2017-2025 ($million)
Table # 39 Asia-pacific In Vitro Diagnostic Multivariate Index Assays Market, 2017-2025 ($million)
Table # 40 Asia-pacific Cancer Biomarkers Market, By Disease 2017-2025 ($million)
Table # 41 Asia-pacific Lung Cancer Market, 2017-2025 ($million)
Table # 42 Asia-pacific Breastcancer Market, 2017-2025 ($million)
Table # 43 Asia-pacific Colorectal Cancer Market, 2017-2025 ($million)
Table # 44 Asia-pacific Prostate Cancer Market, 2017-2025 ($million)
Table # 45 Human Specimens For Cancer Biomarker Discovery
Table # 46 Asia-pacific Cervical Cancer Market, 2017-2025 ($million)
Table # 47 Lists Of Fda-qualified Biomarkers
Table # 48 Asia-pacific Other Cancer Market, 2017-2025 ($million)
Table # 49 Estimated New Cancer Cases And Deaths For 2017, By Sex
Table # 50 Asia-pacific Cancer Biomarkers Market, 2017-2025($ Million)
Figures List
Figure # 1 Increasing Number Of People Living With Cancer Across The Globe For Period 2012-2020 (Million)
Figure # 2 Most Common Cancer Causing Deaths In 2015
Figure # 3 Pharmacogenomic Biomarkers Information In Drug Labeling
Figure # 4 Percentages Of Patients Ineffective For Particular Drug
Figure # 5 List Of Cleared Or Approved Companion Diagnostic Devices (Imaging Tools And In Vitro) By Fda
Figure # 6 Asia-pacific Genetic Methods Market 2017-2025 ($million)
Figure # 7 Asia-pacific Dna Arrays Market 2017-2025 ($million)
Figure # 8 Asia-pacific Polymerase Chain Reaction Market 2017-2025 ($million)
Figure # 9 Asia-pacific Reverse Transcriptase Polymerase Chain Reaction Market 2017-2025 ($million)
Figure # 10 Asia-pacific Fluorescent In Situ Hybridization Market 2017-2025 ($million)
Figure # 11 Asia-pacific Southern Blot Market 2017-2025 ($million)
Figure # 12 Asia-pacific Imaging Market 2017-2025 ($million)
Figure # 13 Asia-pacific Magnetic Resonance Imaging Market 2017-2025 ($million)
Figure # 14 Asia-pacific Computed Tomography Market 2017-2025 ($million)
Figure # 15 Asia-pacific Positron Emission Tomography Market 2017-2025 ($million)
Figure # 16 Asia-pacific Ultrasound Market 2017-2025 ($million)
Figure # 17 Asia-pacific Single Photon Emission Computed Tomography Market 2017-2025 ($million)
Figure # 18 Asia-pacific X-ray Market 2017-2025 ($million)
Figure # 19 Asia-pacific Magnetic Resonance Spectroscopy Market 2017-2025 ($million)
Figure # 20 Asia-pacific Biophotonics Market 2017-2025 ($million)
Figure # 21 Asia-pacific Protein Methods Market 2017-2025 ($million)
Figure # 22 Asia-pacific Mass Spectrometry Market 2017-2025 ($million)
Figure # 23 Asia-pacific Immunohistochemistry Market 2017-2025 ($million)
Figure # 24 Asia-pacific Metabolomics Market 2017-2025 ($million)
Figure # 25 Asia-pacific Genomics And Genetic Markers Market 2017-2025 ($million)
Figure # 26 Asia-pacific Proteomics Market 2017-2025 ($million)
Figure # 27 Asia-pacific Dna Microarrays Market 2017-2025 ($million)
Figure # 28 Asia-pacific Immunoassays Market 2017-2025 ($million)
Figure # 29 Asia-pacific Immunohistochemical Tests Market 2017-2025 ($million)
Figure # 30 Asia-pacific Pharmacogenomics Market 2017-2025 ($million)
Figure # 31 Asia-pacific Molecular (Dna And Genomic) Diagnostic Assays Market 2017-2025 ($million)
Figure # 32 Asia-pacific Flow Cytometry Market 2017-2025 ($million)
Figure # 33 Asia-pacific Monoclonal Antibodies Market 2017-2025 ($million)
Figure # 34 Asia-pacific Stem Cell Markers Market 2017-2025 ($million)
Figure # 35 Asia-pacific In Vitro Diagnostic Multivariate Index Assays Market 2017-2025 ($million)
Figure # 36 Asia-pacific Lung Cancer Market, 2017-2025 ($million)
Figure # 37 New Cases Of Lung & Bronchus Cancer And Associated Deaths, 2015
Figure # 38 Asia-pacific Breastcancer Market 2017-2025 ($million)
Figure # 39 Asia-pacific Colorectal Cancer Market 2017-2025 ($million)
Figure # 40 Statistics Of Colorectal Cancer In 2016
Figure # 41 Asia-pacific Prostate Cancer Market 2017-2025 ($million)
Figure # 42 Asia-pacific Cervical Cancer Market 2017-2025 ($million)
Figure # 43 Asia-pacific Other Cancer Market 2017-2025 ($million)
Figure # 44 China Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 45 India Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 46 Japan Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 47 South Korea Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 48 Australia Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 49 Rest Of Asia-pacific Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 50 Market Share Analyses Of Key Players 2016 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report